Key Metrics
CiteScore 

1.8
H-Index 

7
SJR 

Q3Oncology

SNIP 

0.29
Recommended pre-submission checks
Powered by 

Topics Covered on Journal of Immunotherapy and Precision Oncology
Journal of Immunotherapy and Precision Oncology Journal Specifications
| Overview | |
| Publisher | Innovative Healthcare Institute |
| Language | English |
| Article Processing Charges | USD 2400 |
| Publication Time | 24 |
| Editorial Review Process | Double anonymous peer review |
| General Details | |
| Language | English |
| Website URL | Visit website |
| Publication Details | |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| License type | CC BY, CC BY-NC-ND, Public domain |
| OA statement | Visit website |
View less
Planning to publish in Journal of Immunotherapy and Precision Oncology ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Journal of Immunotherapy and Precision Oncology
Replication-Competent, Tumor-Specific Immuno-Gene Vectors Allow for Exchange of Transgenes and Lead to Viral Persistence Following IV Administration
- 1 Nov 2025
- Journal of Immunotherapy and Precision Oncology
Lung Cancer Outcomes in Vietnam: A 6-Year Retrospective Study
- 1 Nov 2025
- Journal of Immunotherapy and Precision Oncology
Characterizing Inquiries About Novel Cancer Therapies: Findings from the National Cancer Institute’s Cancer Information Service
- 20 Oct 2025
- Journal of Immunotherapy and Precision Oncology
Phase 2 Study of Monotherapy with Pembrolizumab for Advanced Adrenocortical Carcinoma
- 6 Oct 2025
- Journal of Immunotherapy and Precision Oncology
Prevalence of Molecular Mutations in Non–Small Cell Lung Cancer and Current Treatment Approaches in the MENA Region: Systematic Review and Expert Opinion
- 26 Aug 2025
- Journal of Immunotherapy and Precision Oncology
Immunotherapy and Targeted Therapies in Sarcoma: Proposed Synergy with Combination Treatment
- 25 Aug 2025
- Journal of Immunotherapy and Precision Oncology
Replication-Competent, Tumor-Specific Immuno-Gene Vectors Allow for Exchange of Transgenes and Lead to Viral Persistence Following IV Administration
- 1 Nov 2025
- Journal of Immunotherapy and Precision Oncology
Lung Cancer Outcomes in Vietnam: A 6-Year Retrospective Study
- 1 Nov 2025
- Journal of Immunotherapy and Precision Oncology
Characterizing Inquiries About Novel Cancer Therapies: Findings from the National Cancer Institute’s Cancer Information Service
- 20 Oct 2025
- Journal of Immunotherapy and Precision Oncology
Phase 2 Study of Monotherapy with Pembrolizumab for Advanced Adrenocortical Carcinoma
- 6 Oct 2025
- Journal of Immunotherapy and Precision Oncology
Prevalence of Molecular Mutations in Non–Small Cell Lung Cancer and Current Treatment Approaches in the MENA Region: Systematic Review and Expert Opinion
- 26 Aug 2025
- Journal of Immunotherapy and Precision Oncology
Immunotherapy and Targeted Therapies in Sarcoma: Proposed Synergy with Combination Treatment
- 25 Aug 2025
- Journal of Immunotherapy and Precision Oncology